Year-End Report

RICCHETTI INCORPORATED for BOSTON SCIENTIFIC CORPORATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$90,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
Year-End Report (this page) Jan 24, 2008 $90,000 Replaced
Year-End Amendment Jul 7, 2009 $90,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Consumer Issues/Safety/Products CSP

issues related to FDA medical device user fees

LobbyistCovered position, as disclosed
JEFF RICCHETTI N/A
STEVE RICCHETTI N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Issues relating to the reauthorization of MDUFMA (FDA Amendments Act, HR 2900, and S 1082) Issues relating to CHAMP Act (HR 1535, S. 895) Issues relating to disclosure of payments to providers

LobbyistCovered position, as disclosed
JEFF RICCHETTI N/A
STEVE RICCHETTI N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1535 (110th), H.R. 2900 (110th), S. 895 (110th)

Medicare/Medicaid MMM

Issues related to Medicare reimbursement for certain medical devices Issues related to Medicare coverage of remote monitoring devices Issues related to disclosure of device pricing in sales to hospitals (price transparency legislation) Issues related to comparative effectiveness research

LobbyistCovered position, as disclosed
JEFF RICCHETTI N/A
STEVE RICCHETTI N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.